PL3116891T3 - Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania - Google Patents

Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania

Info

Publication number
PL3116891T3
PL3116891T3 PL15708522T PL15708522T PL3116891T3 PL 3116891 T3 PL3116891 T3 PL 3116891T3 PL 15708522 T PL15708522 T PL 15708522T PL 15708522 T PL15708522 T PL 15708522T PL 3116891 T3 PL3116891 T3 PL 3116891T3
Authority
PL
Poland
Prior art keywords
cleaning steps
immunoglobulin purification
immunoglobulin
purification
cleaning
Prior art date
Application number
PL15708522T
Other languages
English (en)
Inventor
Ferenc FELFÖLDI
Zsuzsa BENKÖ
Melinda GÁSPÁR
Original Assignee
Richter Gedeon Nyrt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU1400131A external-priority patent/HUP1400131A1/hu
Priority claimed from HU1500053A external-priority patent/HUP1500053A1/hu
Application filed by Richter Gedeon Nyrt. filed Critical Richter Gedeon Nyrt.
Publication of PL3116891T3 publication Critical patent/PL3116891T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26Cation exchangers for chromatographic processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20Anion exchangers for chromatographic processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/165Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
PL15708522T 2014-03-10 2015-03-09 Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania PL3116891T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU1400131A HUP1400131A1 (hu) 2014-03-10 2014-03-10 Immunoglobulin tisztítása elõtisztítási lépések alkalmazásával
HU1500053A HUP1500053A1 (hu) 2015-02-09 2015-02-09 Immunglobulin tisztítása elõtisztítási lépések alkalmazásával
PCT/EP2015/054862 WO2015135884A1 (en) 2014-03-10 2015-03-09 Immunoglobulin purification using pre-cleaning steps
EP15708522.6A EP3116891B1 (en) 2014-03-10 2015-03-09 Immunoglobulin purification using pre-cleaning steps

Publications (1)

Publication Number Publication Date
PL3116891T3 true PL3116891T3 (pl) 2020-07-27

Family

ID=89991731

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15708522T PL3116891T3 (pl) 2014-03-10 2015-03-09 Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania

Country Status (15)

Country Link
US (1) US10487138B2 (pl)
EP (2) EP3674310A1 (pl)
JP (1) JP6293907B2 (pl)
KR (1) KR101921552B1 (pl)
CN (1) CN106103465B (pl)
CA (1) CA2930350C (pl)
DK (1) DK3116891T3 (pl)
ES (1) ES2784749T3 (pl)
HR (1) HRP20200711T1 (pl)
HU (1) HUE048782T2 (pl)
LT (1) LT3116891T (pl)
PL (1) PL3116891T3 (pl)
PT (1) PT3116891T (pl)
SI (1) SI3116891T1 (pl)
WO (1) WO2015135884A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3116891T3 (pl) 2014-03-10 2020-07-27 Richter Gedeon Nyrt. Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
JP6851109B2 (ja) * 2016-06-16 2021-03-31 Jsr株式会社 抗体を精製する方法及び担体を洗浄する方法
EP3472177B1 (en) * 2016-06-17 2024-08-14 F. Hoffmann-La Roche AG Purification of multispecific antibodies
WO2018051348A1 (en) * 2016-09-14 2018-03-22 Insight Biopharmaceutical Ltd. Methods of purifying and qualifying antibodies
KR20190131082A (ko) * 2017-03-24 2019-11-25 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 재조합 항체 단편을 정제하는 방법
EP3672981A4 (en) 2017-08-22 2021-09-15 Biogen MA Inc. METHOD OF PURIFYING ANTIBODIES WITH AGGREGATES WITH REDUCED HIGH MOLECULAR WEIGHT
KR20190047376A (ko) * 2017-10-27 2019-05-08 주식회사 녹십자 개선된 면역글로불린의 정제방법
WO2019173731A1 (en) * 2018-03-08 2019-09-12 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resin
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
GB201805142D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Bioprocess R&D Ab Separation method
EP3823594A1 (en) * 2018-07-19 2021-05-26 Ichnos Sciences S.A. Liquid antibody formulation
KR102209790B1 (ko) * 2018-12-20 2021-02-01 에이치케이이노엔 주식회사 친화성 크로마토그래피를 이용한 백신용 바이러스 정제방법
EP3903102B1 (en) * 2018-12-30 2023-04-12 F. Hoffmann-La Roche AG Ph-gradient spr-based binding assay
EP3941606A4 (en) * 2019-03-21 2022-12-07 Agency for Science, Technology and Research METHOD FOR CAPTURING AND/OR PURIFYING A TARGET
HU231498B1 (hu) * 2019-04-04 2024-05-28 Richter Gedeon Nyrt Immunglobulinok affinitás kromatográfiájának fejlesztése kötést megelőző flokkulálás alkalmazásával
MA56132A (fr) * 2019-06-10 2022-04-13 Takeda Pharmaceuticals Co Procédés de purification d'anticorps et compositions associées
EP4025336A4 (en) 2019-09-05 2024-01-17 Bio-Rad Laboratories, Inc. ANION EXCHANGE/HYDROPHOBIC RESINS FOR MIXED MODE CHROMATOGRAPHY
CN117355538A (zh) * 2020-04-10 2024-01-05 等离子体技术有限责任公司 简化高效分离蛋白质的组合物和方法
CN113563469A (zh) * 2020-04-28 2021-10-29 江苏中新医药有限公司 高回收率纯化阿达木单抗的方法
AU2021265591A1 (en) * 2020-05-01 2022-12-22 Kashiv Biosciences, Llc An improved process of purification of protein
AU2022361768A1 (en) * 2021-10-08 2024-05-02 Kashiv Biosciences, Llc Separation of pre-peak and post-peak in fusion protein sample by using size exclusion high performance liquid chromatography
CA3234491A1 (en) * 2021-10-08 2023-04-13 Kashiv Biosciences, Llc Separation of pre-peak in fusion protein sample by using size exclusion high performance liquid chromatography
CN114133446A (zh) * 2021-12-31 2022-03-04 方坦思(上海)生物医药有限公司 单克隆抗体的纯化方法
CN115304673B (zh) * 2022-06-24 2024-10-01 上海赛伦生物技术股份有限公司 一种马抗破伤风特异性免疫球蛋白F(ab’)2的纯化方法及其应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2034239T3 (es) * 1987-07-16 1993-04-01 Schering Corporation Purificacion de gm-csf.
CA1341235C (en) 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use
US4983722A (en) 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
WO1991018975A1 (en) * 1990-05-31 1991-12-12 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method for purifying hiv reverse transcriptase
DK0610201T4 (da) 1991-03-18 2008-02-04 Centocor Inc Monoklonale og kimære antistoffer, der er specifikke for human tumornekrosefaktor
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
EP0752248B1 (en) 1992-11-13 2000-09-27 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
DE69721548T2 (de) 1996-02-09 2004-04-01 Abbott Laboratories(Bermuda)Ltd. HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN
EP1787999B1 (en) 1997-04-07 2010-08-04 Genentech, Inc. Anti-VEGF antibodies
WO2001015011A2 (en) 1999-08-26 2001-03-01 Symtec Limited Methods and devices for selecting data files
ES2907826T3 (es) 2001-06-26 2022-04-26 Amgen Inc Anticuerpos para OPGL
US20030040027A1 (en) * 2001-08-16 2003-02-27 Gerd Ritter Method for determining protein component in a biological sample
DE10155984A1 (de) 2001-11-15 2003-05-28 Boehringer Ingelheim Pharma Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices
DK1501369T3 (en) 2002-04-26 2015-09-28 Genentech Inc Non-affinity purification of proteins
AU2004215653B2 (en) 2003-02-28 2011-03-17 Lonza Biologics Plc. Antibody purification by protein A and ion exchange chromatography
EP1614693A4 (en) 2003-03-31 2006-07-19 Kirin Brewery PURIFICATION OF A HUMAN MONOCLONAL ANTIBODY AND A HUMAN POLYCLONAL ANTIBODY
US7485704B2 (en) 2003-07-28 2009-02-03 Genentech, Inc. Reducing protein A leaching during protein A affinity chromatography
EP1689777B1 (en) * 2003-11-05 2007-04-25 Ares Trading S.A. Process for the purification of il-18 binding protein
CA2552639C (en) * 2004-02-27 2012-05-01 Ge Healthcare Bio-Sciences Ab A process for the purification of antibodies
CA2581208A1 (en) * 2004-08-30 2006-03-09 Lonza Biologics Plc. Affinity- plus ion exchange- chromatography for purifying antibodies
DK2840090T3 (en) 2007-10-30 2018-04-23 Genentech Inc Antibody purification by cation exchange chromatography
WO2009138484A2 (en) 2008-05-15 2009-11-19 Novo Nordisk A/S Antibody purification process
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
EP2360183B1 (en) 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Antibody purification method by mixed mode chromatography utilizing an arginine-containing loading solution
EP2456789A1 (en) * 2009-07-24 2012-05-30 F. Hoffmann-La Roche AG Optimizing the production of antibodies
IN2012DN00338A (pl) 2009-08-07 2015-05-22 Millipore Corp
CN108409829A (zh) * 2009-09-01 2018-08-17 弗·哈夫曼-拉罗切有限公司 通过改进的a蛋白洗脱增强的蛋白质纯化
US20120208986A1 (en) 2009-10-20 2012-08-16 Wenger Marc D Use of mixed mode chromatography for the capture and purification of basic antibody products
US20130116413A1 (en) 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
ES2637613T5 (es) 2010-05-25 2022-07-20 Hoffmann La Roche Procedimientos de purificación de polipéptidos
US20120264920A1 (en) * 2010-10-11 2012-10-18 Abbott Laboratories Processes for purification of proteins
SI2731677T1 (sl) * 2011-07-11 2018-09-28 Glenmark Pharmaceuticals S.A. Protitelesa, ki se vežejo na OX40 in njihove uporabe
US20140288278A1 (en) 2011-10-31 2014-09-25 Joseph Nti-Gyabaah Chromatography process for resolving heterogeneous antibody aggregates
RS58472B1 (sr) 2011-11-02 2019-04-30 Hoffmann La Roche Hromatografija preopterećenja i eluata
JP6297029B2 (ja) * 2012-05-31 2018-03-20 エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ 多様な官能基を有する粒子による免疫グロブリンg調製物のクロマトグラフィー精製
WO2013189544A1 (en) * 2012-06-21 2013-12-27 Synthon B.V. Method of purifying an antibody
PL3116891T3 (pl) 2014-03-10 2020-07-27 Richter Gedeon Nyrt. Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania

Also Published As

Publication number Publication date
PT3116891T (pt) 2020-05-18
WO2015135884A1 (en) 2015-09-17
CA2930350A1 (en) 2015-09-17
JP2017507907A (ja) 2017-03-23
CN106103465B (zh) 2021-01-08
EP3116891B1 (en) 2020-02-12
SI3116891T1 (sl) 2020-07-31
KR20160124107A (ko) 2016-10-26
HRP20200711T1 (hr) 2020-07-24
JP6293907B2 (ja) 2018-03-14
CA2930350C (en) 2021-04-06
EP3674310A1 (en) 2020-07-01
US10487138B2 (en) 2019-11-26
LT3116891T (lt) 2020-03-25
KR101921552B1 (ko) 2018-11-23
US20170058019A1 (en) 2017-03-02
ES2784749T3 (es) 2020-09-30
CN106103465A (zh) 2016-11-09
EP3116891A1 (en) 2017-01-18
HUE048782T2 (hu) 2020-08-28
DK3116891T3 (da) 2020-05-04

Similar Documents

Publication Publication Date Title
PL3116891T3 (pl) Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania
ZA201606906B (en) Modified j-chain
IL251508A0 (en) Anti-TNF compounds
PL3127502T3 (pl) Układ czyszczący
GB201410262D0 (en) Novel method
HUE050138T2 (hu) Eljárás IL-15/IL-15Ralfa bázisú konjugátumok tisztítására
GB201419859D0 (en) No title listed
EP3118210A4 (en) Method for purifying immunoglobulin
EP3118209A4 (en) Method for purifying immunoglobulin
SG11201607098SA (en) Antibody purification process
SG11201606811VA (en) Fractionation method
SG11201607341SA (en) Robust antibody purification
EP3168225A4 (en) Fidaxomicin purification method
GB201413225D0 (en) Solder cleaning system
GB201600158D0 (en) Purification method
GB201504280D0 (en) Ancillary additive manufacturing system
GB201421962D0 (en) Filtration method
GB201405591D0 (en) Heatseal
HUP1400131A1 (hu) Immunoglobulin tisztítása elõtisztítási lépések alkalmazásával
HUP1500053A1 (hu) Immunglobulin tisztítása elõtisztítási lépések alkalmazásával
GB201520903D0 (en) Purification method
GB201617240D0 (en) Purification process
GB201512073D0 (en) Vehicle cleaning method
GB201512950D0 (en) Vehicle cleaning method
GB2523168B (en) Vehicle cleaning apparatus